ADBIOTECH Announces Resolution to Convene Extraordinary General Meeting
ADBIOTECH's board resolved to convene an extraordinary general meeting on August 11, 2026.
Details of the agenda items will be disclosed via a corrective filing once finalized; no specific proposals have been announced yet.
The record date for voting rights is set as July 13, 2026.
This disclosure is part of standard corporate procedure and has limited short-term impact on stock price or enterprise value.
[AI Summary]This filing is a procedural meeting notice with no substantive agenda, thus no immediate effect on shareholder value. Investors should monitor future filings for specific agenda items.
KOSDAQ Filing Information
Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)